Section 25, The Assisted Reproductive Technology (Regulation) Act, 2021: Preimplantation Genetic Diagnosis
The Assisted Reproductive Technology (Regulation) Act, 2021 (42 of 2021) - Section 25
Text of section 25
Preimplantation Genetic Diagnosis.
(1) The Pre-implantation Genetic testing shall be used to screen the human embryo for known, pre-existing, heritable or genetic diseases only.
(2) The donation of an embryo after Pre-implantation Genetic Diagnosis to an approved research laboratory for research purposes shall be done only--
(a) with the approval of the commissioning couple or woman; and
(b) when the embryo suffers from pre-existing, heritable, life-threatening or genetic diseases.
(3) The National Board may lay down such other conditions as it deems fit in the interests of the Pre-implantation Genetic testing.
Explanation. --For the purposes of this section, the expression--
(i) "Pre-implantation Genetic Diagnosis" means the genetic diagnosis when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality; and
(ii) "Pre-implantation Genetic testing" means a technique used to identify genetic defects in embryos created through in-vitro fertilisation before pregnancy.
Previous and next
← Section 24Duties of assisted reproductive technology clinics using human gametes and embryosSection 26 →Sex selection
All sections of The Assisted Reproductive Technology (Regulation) Act, 2021
Questions people ask
Is section 25 of the Assisted Reproductive Technology (Regulation) Act, 2021 still in force?
No repeal of the Assisted Reproductive Technology (Regulation) Act, 2021 is recorded.